|
|
TTD Drug ID:
DNC004727
Drug
Information |
Name | Des-AA1,2,5-[D-Trp8,IAmp9]SRIF CH-275 | Indication | Not Available | Experimental | Structure |
Click to save drug structure in 3D MOL format
Click to save drug structure in 2D MOL format
| InChI | 1S/C74H96N14O15S2/c1-42(2)77-37-49-29-27-48(28-30-49)35-57-69(97) 87-62(43(3)90)72(100)84-58(34-47-22-12-7-13-23-47)70(98)88-63(44( 4)91)73(101)85-60(39-89)71(99)86-61(74(102)103)41-105-104-40-52(7 6)64(92)79-54(26-16-17-31-75)65(93)80-55(32-45-18-8-5-9-19-45)66( 94)81-56(33-46-20-10-6-11-21-46)67(95)83-59(68(96)82-57)36-50-38- 78-53-25-15-14-24-51(50)53/h5-15,18-25,27-30,38,42-44,52,54-63,77 -78,89-91H,16-17,26,31-37,39-41,75-76H2,1-4H3,(H,79,92)(H,80,93)( H,81,94)(H,82,96)(H,83,95)(H,84,100)(H,85,101)(H,86,99)(H,87,97)( H,88,98)(H,102,103)/t43-,44-,52-,54-,55-,56+,57+,58+,59+,60+,61+, 62-,63-/m1/s1 | InChIKey | SYHQUPOPQRNSKD-ZDFJKKNGSA-N | Canonical SMILES | CC(C)NCC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(= O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC3=CNC4=CC=CC=C43)CC5=CC=CC=C5) CC6=CC=CC=C6)CCCCN)N)C(=O)O)CO)C(C)O)CC7=CC=CC=C7)C(C)O | Isomeric SMILES | C[C@H]([C@@H]1C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@ H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O) N1)CC2=CC=C(C=C2)CNC(C)C)CC3=CNC4=CC=CC=C43)CC5=CC=CC=C5)CC6=CC=CC=C6) CCCCN)N)C(=O)O)CO)[C@@H](C)O)CC7=CC=CC=C7)O | Target | Somatostatin receptor 1 |  | Inhibitor | [1] | Somatostatin receptor 3 |  | Inhibitor | [1] | Ref 1 | J Med Chem. 2005 Jan 27;48(2):507-14.Somatostatin receptor 1 selective analogues: 2. N(alpha)-Methylated scan. To Reference |
Welcome
to sign our Guestbook.
If you
find any error in data or bug in web service, please kindly report it
to Dr.
Zhu.
Dr.
Chen Yuzong
Deputy Director of Center
for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|